NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Thursday 27 August 2009

Lonza makes offer for Patheon

Lonza has made a non-binding offer to acquire Patheon. Lonza has offered $3.55/share valuing Patheon at $460m. Lonza ceo Stefan Borgas said Lonza was looking to expand its offering to cover more of the manufacturing supply chain and Patheon's finished dosage manufacturing capability would fill a gap. He added that Patheon was one of several opportunities in the area that lonza had been following over the last couple of years.
Reuters

No comments: